Obermatt
See Similar Stocks →

AngioDynamics

NSQ:ANGO · US03475V1017
Health Care Equipment & SuppliesSmall

360

57
Profit price87
Owner Earnings Yield1
Dividend Yield1
Price/Sales70
EV / Gross Profit69
Price/Book38
Return on Capital33
Cash Return on Capital49
Return on Equity41
EBIT Margin39
Gross Profitability88
Accruals77
Owner Earnings Margin51
Sales growth41
Profit growth38
Reinvestment4
Price momentum64
Debt load93
Refinancing64
Debt Payback1
Liquidity1
Analyst ratings100
Opinion Changes50
Price Target Upside56
Market mood4
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

AngioDynamics doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded1992
Employees637
Websiteangiodynamics.com
ISINUS03475V1017
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)D.J. US Medical Equipment
Themes
UrologyCardiovascularHealth DiagnosticsHematologyOncologySurgeryBiomedical EngineeringNephrologyHardwareHealth Care

Description

AngioDynamics, Inc. (AngioDynamics) operates as a medical technology company. The company focuses on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The compan…

Analysis

Middle-of-the-road

AngioDynamics, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
32
2023202420252026

All-time high

94

Mar 2026

All-time low

1

Jan 2023

Average rank

51

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
70
65
95
75
Price/Earnings
95
31
31
4
Price/Book
38
70
97
92
Dividend Yield
1
1
1
1
Value (overall)
64
61
85
51

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare AngioDynamics with its peers
LeMaitre Vascular
NMQ:LMAT
78
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Tactile Systems Technology
NMQ:TCMD
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Becton Dickinson
NYQ:BDX
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Integer
NYQ:ITGR
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Sight Sciences
NSQ:SGHT
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Spectral AI
NAQ:MDAI
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →